“…Donors and Methods: In this prospective randomized trial, 26 healthy volunteers were randomly assigned to a single subcutaneous dose of lenograstim 6 lg/kg plus 8-mg DXM (G-CSF/DXM, n 5 13) or placebo (G-CSF/placebo, n 5 13). Hematological and biochemical parameters were analyzed before and 12, 15,18,21,24,27,29, 36, 48, 60, 72, and 84 h and 7 and 30 days after mobilization. Six G-CSF/DXM subjects underwent standard neutrophil apheresis (NA) 12 and 36 h after mobilization.…”